← Back to Clinical Trials
Recruiting NCT06821282

Surveillance of AMR in DRC

Trial Parameters

Condition Bacteremia
Sponsor University of Oxford
Study Type OBSERVATIONAL
Phase N/A
Enrollment 210
Sex ALL
Min Age 6 Months
Max Age N/A
Start Date 2024-11-11
Completion 2025-03-30

Brief Summary

This study addresses knowledge gaps regarding antimicrobial resistance (AMR) in sub-Saharan Africa, focusing on evaluating the feasibility of AMR surveillance and enhancing local research capacity. Conducted at a general referral hospital in semirural Kinshasa, DRC, the study will investigate bacterial infections, their resistance profiles, and related risk factors, including co-infections such as malaria.

Eligibility Criteria

Patients older than six months who present with a clinically suspected bloodstream infection upon admission to the hospital, or who have been hospitalized for less than 48 hours, and provide written consent (or consent from their caregiver/legal guardian) to participate will be included. Patients with a significant history of healthcare exposure and those with any contraindications for phlebotomy as determined by the clinician's judgment, will be excluded.

Related Trials